These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 92620)

  • 1. Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection.
    Pearson NJ; Towner KJ; McSherry AM; Cattell WR; O'Grady F
    Lancet; 1979 Dec; 2(8154):1205-8. PubMed ID: 92620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects.
    Grüneberg RN; Smellie JM; Leakey A; Atkin WS
    Br Med J; 1976 Jul; 2(6029):206-8. PubMed ID: 974493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
    Wilson JM; Guiney DG
    N Engl J Med; 1982 Jan; 306(1):16-20. PubMed ID: 7053467
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae.
    Towner KJ; Slack RC
    Eur J Clin Microbiol; 1986 Oct; 5(5):502-6. PubMed ID: 3490973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-trimoxazole resistant coliforms.
    Hart CA; Gibson MF; Mulvihill E; Green HT
    Lancet; 1977 Nov; 2(8047):1081-2. PubMed ID: 72989
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
    Schaeffer AJ; Sisney GA
    J Urol; 1985 Apr; 133(4):628-30. PubMed ID: 3157008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
    Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences: genitourinary infections. A. Infections of the urinary tract. Efficacy of trimethoprim-sulfamethoxazole in bacteriuria.
    Harding GK; Ronald AR
    J Infect Dis; 1973 Nov; 128():Suppl:641-6 p. PubMed ID: 4585964
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
    Wormser GP; Keusch GT; Heel RC
    Drugs; 1982 Dec; 24(6):459-518. PubMed ID: 6759092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance of enterobacteria to the sulfonamide-trimethoprim combination. Course during the last 10 years].
    Goldstein FW; Acar JF
    Presse Med; 1983 May; 12(21):1341-4. PubMed ID: 6222315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.
    Acar JF; Goldstein F; Chabbert YA
    J Infect Dis; 1973 Nov; 128():Suppl:470-7 p. PubMed ID: 4585953
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-trimoxazole resistance in Jamaica.
    Macfarlane DE
    Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 15. Perils of prophylaxis.
    Jacoby GA
    N Engl J Med; 1982 Jan; 306(1):43-4. PubMed ID: 7053471
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance.
    Lacey RW; Lord VL; Gunasekera HK; Leiberman PJ; Luxton DE
    Lancet; 1980 Jun; 1(8181):1270-3. PubMed ID: 6104083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim resistance in enterobacteria isolated in Chile.
    Urbina R; Prado V; Canelo E
    J Antimicrob Chemother; 1989 Jan; 23(1):143-9. PubMed ID: 2663804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.
    Anderson JD; Lacey RW; Lewis EL; Sellin MA
    J Clin Pathol; 1974 Aug; 27(8):619-22. PubMed ID: 4425219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of the antibacterial action of cotrimoxazole in vitro.
    Lewis EL; Anderson JD; Lacey RW
    J Clin Pathol; 1974 Feb; 27(2):87-91. PubMed ID: 4596417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
    King CH; Shlaes DM; Dul MJ
    J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.